口服补充因子 D 抑制剂danicopan 对于阴性夜间血红蛋白尿症
Bo Xu1,2,3,4,5, Jiecan Zhou1,2,3,4,5
1School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Expert review of clinical pharmacology
|September 11, 2024
概括
丹尼科潘是治疗阴性夜间血红蛋白尿症 (PNH) 的新疗法,通过向外血管血解,显著提高血红蛋白水平. 本综述评估了其在PNH患者的临床有效性和安全性.
科学领域:
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 透性夜间血红蛋白尿 (PNH) 是一种罕见的血液疾病,具有血液溶解,血栓形成和骨髓衰竭.
- 血管外血液溶解是PNH的一个关键表现.
研究的目的:
- 审查danicopan在治疗PNH的成年人中的临床疗效和安全性.
- 检查丹尼科潘在PNH外血管血解管理中的作用.
主要方法:
- 在PubMed,Web of Science,Springer,Elsevier和Wiley的系统文献搜索到2024年5月6日.
- 对临床试验数据的审查,包括关键的第3期ALPHA试验.
主要成果:
- 丹尼科潘向替代补充途径,抑制C3片段介导的外血管血解.
- 在ALPHA试验中,danicopan显著增加了血红蛋白水平 (p < 0.0001),60%的患者达到≥2g/dL的增加,而安慰剂组为0%.
- 常见的不良事件包括头痛和上呼吸道感染.
结论:
- 丹尼科潘在增加外血管血解PNH患者的血红蛋白水平方面表现出显著的有效性.
- 该药物是口服的,剂量调整是可能的,并且在使用之前需要对封装细菌进行疫苗接种.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
652
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
652
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
160
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
160